ArticleJournal of personalized medicine2025

Baseline Findings from Dual-Phase Amyloid PET Study in Newly Diagnosed Multiple Sclerosis: Exploring Its Potential as a Biomarker of Myelination and Neurodegeneration.

José María Barrios-López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.